Quadcap Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$77.2K 400
2024
Q4
$77.2K Buy
+100
New +$82.8K 0.01% 371

Other funds holding LLY

Quadcap Wealth Management's LLY Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Eli Lilly (LLY) stake by 7.9% in Q1 2026, selling an estimated $155K and leaving 1,790 shares worth $1.65M. The position accounts for 0.19% of the portfolio, ranked #104.

Quadcap Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.68M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quadcap Wealth Management held 1,790 shares of Eli Lilly worth $1.65M as of Q1 2026.
  • Quadcap Wealth Management sold 153 Eli Lilly shares in Q1 2026, an estimated $155K.
  • Eli Lilly made up 0.19% of Quadcap Wealth Management's portfolio in Q1 2026, its #104 holding.
  • Quadcap Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Quadcap Wealth Management's Eli Lilly position peaked at $2.68M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.